S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4797 Reports
🤖 AI Analyzed
Recent
📄 Page 250 of 400
FORWARD AIR CORP
10-K March 11, 2026

Key Highlights

  • Acquisition of Omni Logistics significantly expands global reach, diversifies se...
  • Expected to achieve $75 million in annual synergies within two years post-Omni L...
  • Management anticipates mid-single-digit revenue growth and double-digit EPS accr...
Read Analysis
🤖 AI Generated
TELECOM ARGENTINA SA
20-F March 11, 2026

Key Highlights

  • Maintained a stable Adjusted EBITDA margin of around 30% in 2023, demonstrating ...
  • Strategic investments in 5G licenses and fiber infrastructure are underway, with...
  • Expanded subscriber base across mobile (24 million), broadband (4.2 million), an...
Read Analysis
🤖 AI Generated
METROPOLITAN LIFE INSURANCE CO
10-K March 11, 2026

Key Highlights

  • Robust financial performance with $65 billion in revenue, $5.5 billion net incom...
  • Strong financial health, boasting $850 billion in total assets, $750 billion in ...
  • Diversified global business across U.S., International, and Investment Managemen...
Read Analysis
🤖 AI Generated
ICL Group Ltd.
20-F March 11, 2026

Key Highlights

  • Achieved robust operational performance with an EBITDA of $1.412 billion in 2024...
  • Secured and extended a $1.55 billion Sustainability-Linked Revolving Credit Faci...
  • Demonstrated strong commitment to ESG principles by tying interest rates of the ...
Read Analysis
🤖 AI Generated
MEDALLION FINANCIAL CORP
10-K March 10, 2026

Key Highlights

  • Solid growth in consumer and commercial lending segments, which are now the larg...
  • Strong financial health evidenced by increased shareholder equity and capital ra...
  • Strategic shift towards diversified lending has proven effective in mitigating c...
Read Analysis
🤖 AI Generated
KVH INDUSTRIES INC \DE\
10-K March 10, 2026

Key Highlights

  • Significant turnaround to $6.2 million net profit in 2025 from a $2.5 million lo...
  • Strong 4.8% revenue growth to $152.5 million, with high-margin Airtime Service r...
  • Successful LEO Service expansion, securing over 1,500 new subscriptions, and mul...
Read Analysis
🤖 AI Generated
SIGA TECHNOLOGIES INC
10-K March 10, 2026

Key Highlights

  • TPOXX is the only FDA-approved oral antiviral for smallpox, securing a unique ma...
  • Long-standing BARDA contract provides stable revenue visibility through at least...
  • Robust financial health with negligible debt and commitment to shareholder retur...
Read Analysis
🤖 AI Generated
WILLIS LEASE FINANCE CORP
10-K March 10, 2026

Key Highlights

  • Leading global lessor of commercial aircraft engines with approximately $2.8 bil...
  • Strong operational performance in 2025 with 94.9% of total income from leasing a...
  • Strategic shift towards more stable, longer-duration contracts, with shorter-ter...
Read Analysis
🤖 AI Generated
CORE MOLDING TECHNOLOGIES INC
10-K March 10, 2026

Key Highlights

  • Specialized manufacturer of critical components for diverse industries (recreati...
  • Maintains a strong competitive position through specialized expertise, operation...
  • Leadership is focused on long-term value creation, implementing strategic initia...
Read Analysis
🤖 AI Generated
Pulmonx Corp
10-K March 10, 2026

Key Highlights

  • Pulmonx Corp achieved a strong 25% revenue growth, reaching $150.5 million in 20...
  • The company significantly improved its net loss, reducing it from $75.1 million ...
  • Pulmonx maintains a solid financial position with $205.3 million in cash, cash e...
Read Analysis
🤖 AI Generated
Western New England Bancorp, Inc.
10-K March 10, 2026

Key Highlights

  • Robust balance sheet, healthy capital ratios (11.5% CET1), and solid asset quali...
  • Strong loan portfolio expansion (6.2% growth) driven by commercial real estate a...
  • Strategic investments in digital transformation and commercial lending expansion...
Read Analysis
🤖 AI Generated
MEDICINOVA INC
10-K March 10, 2026

Key Highlights

  • Positive Phase 2b SPRINT-MS trial for MN-166 in progressive MS, demonstrating si...
  • MN-166 (ibudilast) offers unique neuroprotective and anti-inflammatory propertie...
  • MN-001 (tipelukast) completed Phase 2 studies for NAFLD and hypertriglyceridemia...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage